BIOANALYTICAL SYSTEMS, INC.
|
(Exact name of registrant as specified in its charter)
|
Indiana
|
0-23357
|
35-1345024
|
||
(State or other
jurisdiction of
incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
2701 KENT AVENUE
WEST LAFAYETTE, INDIANA
|
47906-1382
|
|
(Address of principal executive offices)
|
(Zip Code)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
|
Item2.02. | Results of Operations and Financial Condition. |
Item 9.01.
|
Financial Statements and Exhibits.
|
|
(a)
|
Not applicable.
|
|
(b)
|
Not applicable.
|
|
(c)
|
Not applicable.
|
|
(d)
|
Exhibits
|
|
99.1
|
Bioanalytical Systems, Inc. press release, issued December 20, 2011.
|
Bioanalytical Systems, Inc.
|
||
Date: December 20, 2011
|
By:
|
/s/ Michael R. Cox
|
Michael R. Cox
|
||
Vice President, Finance and Administration, Chief Financial Officer and Treasurer
|
Exhibit No.
|
Description
|
|
99.1
|
Bioanalytical Systems, Inc. press release, issued December 20, 2011.
|